ICD-10 Code for PSA Lab Testing
For asymptomatic men requesting PSA screening for prostate cancer detection, use ICD-10 code Z12.5 (Encounter for screening for malignant neoplasm of prostate). 1
Primary Screening Code
- Z12.5 is the standard code for PSA screening in asymptomatic men after shared decision-making discussion about the benefits and harms of screening 1
- This code should be used for men aged 50-69 years who have completed the shared decision-making process recommended by guidelines 1
- The code applies to both initial and repeat screening encounters, whether testing is done annually or biennially 1
Risk-Based Secondary Codes
When screening high-risk populations, add appropriate secondary codes to Z12.5:
- Z80.42 (Family history of malignant neoplasm of prostate) for men with first-degree relatives diagnosed with prostate cancer 1
- Z15.03 (Genetic susceptibility to malignant neoplasm of prostate) for high-risk populations including African American men 1
- These secondary codes are particularly important for men aged 45-49 years who qualify for earlier screening due to elevated risk 1
Alternative Codes for Symptomatic Patients
Do not use Z12.5 if the patient has lower urinary tract symptoms or other prostate-related complaints. Instead, use:
- N40.0 (Benign prostatic hyperplasia without lower urinary tract symptoms) when PSA monitoring is indicated for known BPH 1
- N40.1 (Benign prostatic hyperplasia with lower urinary tract symptoms) when the patient has voiding difficulties or frequency 1
- These codes reflect that PSA testing is being done for diagnostic or monitoring purposes rather than screening 1
Critical Documentation Requirements
- The shared decision-making discussion must be documented in the medical record before using Z12.5, including discussion of the potential 1.3 deaths prevented per 1000 men screened over 13 years versus harms such as false positives, overdiagnosis, and treatment complications 1
- Document whether the patient chose to proceed with screening after understanding that the chances of harm are greater than the chances of benefit for most men 2
Common Coding Pitfalls
- Never use Z12.5 for men with elevated PSA being monitored or worked up—this is diagnostic testing, not screening 1
- Avoid using Z12.5 for men over age 75 unless they are exceptionally healthy with minimal comorbidity, as screening in this population substantially increases overdetection 3, 4
- Do not use screening codes when PSA is ordered to evaluate symptoms—symptomatic patients require diagnostic codes 1